Home Health Renal Biomarkers Market Size, Trends, Growth and Forecast 2022 to 2027

Renal Biomarkers Market Size, Trends, Growth and Forecast 2022 to 2027

Renal Biomarkers Market

According to the latest report by IMARC Group, titled “Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global renal biomarkers market. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global renal biomarkers market reached a value of US$ 1.13 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.88 Billion by 2027, exhibiting a CAGR of 8.70% during 2022-2027.

Renal biomarkers refer to proteins, liquids, microRNAs, metabolites, genes, lipids, or proteomic patterns on a urinalysis. These patterns aid in ascertaining the glomerular filtration rate (GFR) of the kidney to determine its proper functioning and evaluate pathogenic procedures or pharmacological responses to therapeutic interventions. In recent years, renal biomarkers have gained traction in hospital and diagnostic laboratories across the globe due to their ability to predict disease progression and compute drug dosage.

Request a PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/renal-biomarkers-market/requestsample

Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

One of the primary factors driving the market is the rising prevalence of individuals diagnosed with chronic kidney disease (CKD) and non-communicable diseases with considerable mortality and morbidity. Additionally, renal biomarkers, along with serum creatinine (SCr), blood urea nitrogen (BUN), urinary albumin or protein, and volume excretion, are extensively utilized to diagnose and monitor chronic kidney disease (CKD).

Besides this, there is widespread adoption of novel biomarkers and process-specific biomarker panels as they share prognostic and diagnostic information and assist in predicting the response to the treatment of glomerulopathies, autosomal dominant polycystic kidney disease (ADPKD), and acute kidney injury. Other major growth-inducing factors include the accessibility and feasibility of this product in all-sized laboratories, development and integration of epigenetics, transcriptomics, metabolomics, proteomics and genomics, growing healthcare industry, increasing geriatric population, and rising number of clinical trials for CKD globally.

Renal Biomarkers Market Report Scope
Report CoverageDetails
Market size value in 2021US$ 1.13 Billion
Market forecast in 2027US$ 1.88 Billion
Growth RateCAGR of 8.70% from 2022 to 2027
Base year for estimation2021
Historical data2016-2021
Forecast period2022-2027

Global Renal Biomarkers Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these top key players include: 

  • Abbott Laboratories
  • Beckman Coulter Inc. (Danaher Corporation)
  • bioMérieux SA
  • BioPorto A/S
  • Bio-Rad Laboratories Inc.
  • Enzo Biochem Inc.
  • F. Hoffmann-La Roche AG
  • PerkinElmer Inc.
  • Randox Laboratories Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Do you know more information, Contact to our analyst athttps://www.imarcgroup.com/renal-biomarkers-market

The report has segmented the market on the basis of region, type, diagnostic technique and end user.

Breakup by Type:

• Functional Biomarker
o Serum Creatinine
o Serum Cystatin C
o Urine Albumin
• Up-regulated Protein
o Neutrophil Gelatinase-Associated Lipocalin (NGAL)
o Kidney Injury Molecule-1
• Others

Breakup by Diagnostic Technique:

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay (CLIA)
  • Liquid Chromatography Mass Spectrometry (LC-MS)

The Breakup by End User:

  • Hospital
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Read More: Construction 4.0 Market – By Solution, Technology, Application, End User and Geography

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Previous articleConstruction 4.0 Market – By Solution, Technology, Application, End User and Geography
Next articleAluminum Hydroxide Market Size, Share, Industry Growth and Analysis 2022-27


Please enter your comment!
Please enter your name here